932374-66-8

Basic information

• Product Name: 2-chloro-4-nitro-5-fluoroanisole
• Synonyms: 2-chloro-4-nitro-5-fluoroanisole
• CAS NO: 932374-66-8
• Molecular Weight: 205.573
• Mol File: 932374-66-8.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-chloro-4-nitro-5-fluoroanisole(CAS DataBase Reference)
• NIST Chemistry Reference: 2-chloro-4-nitro-5-fluoroanisole(932374-66-8)
• EPA Substance Registry System: 2-chloro-4-nitro-5-fluoroanisole(932374-66-8)

Safety Data

• Hazardous Substances Data: 932374-66-8(Hazardous Substances Data)

Upstream product

• 450-89-5 1-chloro-4-fluoro-2-methoxybenzene 
• 524955-92-8 2-chloro-5-fluoro-4-nitrophenol 
• 74-88-4 methyl iodide 

Downstream Products

• 1350765-65-9 C₁₅H₁₂ClNO₆ 
• 1350765-32-0 C₂₁H₁₄Cl₂F₃NO₆S 
• 1350765-45-5 C₂₂H₁₆Cl₂F₃NO₆S 
• 1350765-56-8 C₁₅H₁₄ClNO₄ 
• 1350765-09-1 C₂₇H₂₆Cl₂F₃N₃O₅S 
• 1350765-04-6 C₂₈H₂₈Cl₂F₃N₃O₅S 
• 932374-71-5 1,1-dimethylethyl 4-[(5-methoxy-4-chloro-2-nitrophenyl)amino]piperidinecarboxylate 
• 88581-05-9 4-chloro-5-methoxy-2-nitrophenol 

Relevant articles and documents

NOVEL COMPOUNDS USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS

The present invention relates to novel morpholine, oxazapane and piperidine derivatives that act as ligands for CC chemokine receptors, such as CCR1. The invention also relates to methods of preparing the compounds, compositions containing the compounds, and to methods of treatment using the compounds.

COMPOUNDS WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE

Compounds of formula (I) and salts and solvates are provided: In a first aspect therefore, the invention provides a compound of formula (I) or a salt or solvate thereof: wherein R5 is selected from halogen, C1-6alkyl, C1-6alkyl substituted with one or more fluorine atoms, C1-6 alkoxy, C1-6 alkoxy substituted with one or more fluorine atoms, and cyano; R6 is selected from halogen, C1-6alkyl, C1-6alkyl substituted with one or more fluorine atoms, C3-6cycloalkyl, C3-6cycloalkyl substituted with one or more fluorine atoms, C1-6 alkoxy, C1-6 alkoxy substituted with one or more fluorine atoms, and cyano; and Q is hydrogen or C 1-6 alkyl. The compounds are M1 agonists and are useful for therapy, for example in the treatment of psychotic disorders and cognitive impairment.